GigaMune, Inc
GigaMune, Inc. is a San Francisco-based biotechnology company specializing in the development of in vivo cell therapies for cancer and inherited blood disorders. Their innovative approach involves infusing virus-like gene delivery particles directly into patients to address manufacturing bottlenecks and improve patient access to treatments.
Founded by a team of experienced entrepreneurial scientists, GigaMune is at the forefront of rethinking cell therapy by utilizing novel technologies for molecular targeting, including artificial intelligence and high-throughput genomics. Their pipeline includes in vivo cell therapies for conditions such as multiple myeloma, acute myeloblastic leukemia, and sickle cell disease, with a focus on enhancing efficacy while minimizing medical risks associated with traditional lymphodepletion methods.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.